Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Current Assets (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Current Assets data on record, last reported at $862.2 million in Q4 2025.

  • For Q4 2025, Current Assets changed N/A year-over-year to $862.2 million; the TTM value through Dec 2025 reached $862.2 million, changed N/A, while the annual FY2025 figure was $810.6 million, 34.88% up from the prior year.
  • Current Assets reached $862.2 million in Q4 2025 per PAHC's latest filing, up from $835.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $862.2 million in Q4 2025 and bottomed at $471.7 million in Q1 2021.
  • Average Current Assets over 5 years is $603.4 million, with a median of $583.1 million recorded in 2022.
  • Peak YoY movement for Current Assets: decreased 2.34% in 2024, then surged 46.43% in 2025.
  • A 5-year view of Current Assets shows it stood at $508.6 million in 2021, then grew by 14.37% to $581.7 million in 2022, then grew by 0.84% to $586.6 million in 2023, then dropped by 2.7% to $570.8 million in 2024, then surged by 51.06% to $862.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $862.2 million in Q4 2025, $835.8 million in Q3 2025, and $810.6 million in Q2 2025.